These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 39055375

  • 1. Evaluation of the Ocular Safety of Hollow Mesoporous Organosilica Nanoparticles with Different Tetrasulfur Bond Content.
    Li J, Gao Z, Li N, Yao L, Liu C, Xu C, Ren X, Wang A, Gao S, Wang M, Gao X, Li K, Wang J.
    Int J Nanomedicine; 2024; 19():7123-7136. PubMed ID: 39055375
    [Abstract] [Full Text] [Related]

  • 2. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
    Gautam M, Thapa RK, Poudel BK, Gupta B, Ruttala HB, Nguyen HT, Soe ZC, Ou W, Poudel K, Choi HG, Ku SK, Yong CS, Kim JO.
    Acta Biomater; 2019 Apr 01; 88():448-461. PubMed ID: 30818051
    [Abstract] [Full Text] [Related]

  • 3. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y, Wang B, Chen J, He J, Qiu X.
    Curr Drug Deliv; 2023 Apr 01; 20(9):1337-1350. PubMed ID: 35713141
    [Abstract] [Full Text] [Related]

  • 4. A Facile Way for Fabricating PEGylated Hollow Mesoporous Silica Nanoparticles and Their Drug Delivery Application.
    Teng X, Cheng S, Meng R, Zheng S, Yang L, Ma Q, Jiang W, He J.
    J Nanosci Nanotechnol; 2015 May 01; 15(5):3773-9. PubMed ID: 26505004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T, Geng T, Md A, Banerjee P, Wang B.
    Colloids Surf B Biointerfaces; 2019 Apr 01; 176():185-193. PubMed ID: 30616109
    [Abstract] [Full Text] [Related]

  • 7. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
    Yue J, Luo SZ, Lu MM, Shao D, Wang Z, Dong WF.
    Chem Biol Drug Des; 2018 Aug 01; 92(2):1435-1444. PubMed ID: 29671941
    [Abstract] [Full Text] [Related]

  • 8. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M, Chang C, Liu Z, Chen K, Zhou Y, Zheng G, Huang Z, Xu H, Xu P, Lu B.
    Colloids Surf B Biointerfaces; 2019 Nov 01; 183():110427. PubMed ID: 31408782
    [Abstract] [Full Text] [Related]

  • 9. Shape-Controlled Hollow Mesoporous Silica Nanoparticles with Multifunctional Capping for In Vitro Cancer Treatment.
    Geng H, Chen W, Xu ZP, Qian G, An J, Zhang H.
    Chemistry; 2017 Aug 10; 23(45):10878-10885. PubMed ID: 28580592
    [Abstract] [Full Text] [Related]

  • 10. Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy.
    Ke Y, Xiang C.
    Int J Nanomedicine; 2018 Aug 10; 13():8339-8354. PubMed ID: 30584304
    [Abstract] [Full Text] [Related]

  • 11. ROS-responsive charge reversal mesoporous silica nanoparticles as promising drug delivery system for neovascular retinal diseases.
    Elbedwehy AM, Wu J, Na HK, Baek A, Jung H, Kwon IH, Lee SW, Kim JH, Lee TG.
    J Control Release; 2024 Sep 10; 373():224-239. PubMed ID: 39002796
    [Abstract] [Full Text] [Related]

  • 12. A pH/ROS-responsive, tumor-targeted drug delivery system based on carboxymethyl chitin gated hollow mesoporous silica nanoparticles for anti-tumor chemotherapy.
    Ding X, Yu W, Wan Y, Yang M, Hua C, Peng N, Liu Y.
    Carbohydr Polym; 2020 Oct 01; 245():116493. PubMed ID: 32718608
    [Abstract] [Full Text] [Related]

  • 13. A dual catalytic functionalized hollow mesoporous silica-based nanocarrier coated with bacteria-derived exopolysaccharides for targeted delivery of irinotecan to colorectal cancer cells.
    Fatemi M, Meshkini A, Matin MM.
    Int J Biol Macromol; 2024 Feb 01; 259(Pt 1):129179. PubMed ID: 38181911
    [Abstract] [Full Text] [Related]

  • 14. Unique Advantages of Dendrimers-Structured Mesoporous Silica Nanoparticles over Traditional Hollow Ones in Delivering Bcl2-Functional Converting Peptide for Multidrug Resistant Cancer Treatment.
    Wu Y, Ma F, Yu L, Lin R, Lin S, Guo Z, Zhou M, Li M, Zhang Y, Xie J.
    Adv Healthc Mater; 2024 Sep 01; 13(23):e2400888. PubMed ID: 38626918
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal safety profiles of sol-gel mesoporous silica microparticles and the degradation product (Si(OH)4).
    Sun Y, Huffman K, Freeman WR, Sailor MJ, Cheng L.
    Drug Deliv; 2020 Dec 01; 27(1):703-711. PubMed ID: 32393079
    [Abstract] [Full Text] [Related]

  • 16. Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer.
    Romaní-Cubells E, Martínez-Erro S, Morales V, Chocarro-Calvo A, García-Martínez JM, Sanz R, García-Jiménez C, García-Muñoz RA.
    J Nanobiotechnology; 2024 May 14; 22(1):249. PubMed ID: 38745193
    [Abstract] [Full Text] [Related]

  • 17. Engineering hollow mesoporous silica nanoparticles to increase cytotoxicity.
    Pérez-Garnes M, Gutiérrez-Salmerón M, Morales V, Chocarro-Calvo A, Sanz R, García-Jiménez C, García-Muñoz RA.
    Mater Sci Eng C Mater Biol Appl; 2020 Jul 14; 112():110935. PubMed ID: 32409082
    [Abstract] [Full Text] [Related]

  • 18. Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles.
    Chen L, She X, Wang T, He L, Shigdar S, Duan W, Kong L.
    Nanoscale; 2015 Sep 07; 7(33):14080-92. PubMed ID: 26242620
    [Abstract] [Full Text] [Related]

  • 19. Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery.
    She X, Chen L, Velleman L, Li C, Zhu H, He C, Wang T, Shigdar S, Duan W, Kong L.
    J Colloid Interface Sci; 2015 May 01; 445():151-160. PubMed ID: 25617610
    [Abstract] [Full Text] [Related]

  • 20. Surface functionalized mesoporous silica nanoparticles for intravitreal application of tacrolimus.
    Paiva MRB, Andrade GF, Dourado LFN, Castro BFM, Fialho SL, Sousa EMB, Silva-Cunha A.
    J Biomater Appl; 2021 Mar 01; 35(8):1019-1033. PubMed ID: 33290123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.